Vol. 3 No. 2 (2016): May-August 2016

Published: 2016-08-31

Original Research Articles

  • An Approach to Evaluate Payment-by-Results Agreements

    Clement Tournier, Valerie Deroo, Sara Villa, Giovanni Giuliani, Carlo Lucioni, Silvio Mazzi, Roberto Ravasio
    57-61
    DOI: https://doi.org/10.33393/grhta.2016.410

  • On the New Payment-by-Results Method for Determining the Fair Price of New Drugs. An Application in Oncology

    Enzo Ballatori, Salvatore Palazzo, Benedetta Ruggeri, Donatella Morale, Aldo Filice, Carmela Oriolo, Alberto Vergati, Marianna Napoletano, Isidoro Mazzoni
    62-66
    DOI: https://doi.org/10.33393/grhta.2016.411

  • Economic Evaluation of Ipilimumab in First Line Treatment of Advanced Melanoma in Italy

    Maria De Francesco, Mark Lamotte, Paolo Antonio Ascierto, Paolo Di Rienzo, Yumi Asukai
    67-79
    DOI: https://doi.org/10.33393/grhta.2016.412

  • Therapeutic Strategies and Health Costs of Patients Admitted for a Cardiovascular Event in Italy

    Carlo Lucioni, Silvio Mazzi, Elisa Rossi, Rita Rielli, Silvia Calabria, Aldo Pietro Maggioni
    80-91
    DOI: https://doi.org/10.33393/grhta.2016.413

  • Economic Evaluation of Canagliflozin versus Glimepiride and Sitagliptin in Dual Therapy with Metformin for the Treatment of Type 2 Diabetes in Italy

    Roberto Ravasio, Patrizia Pisarra, Roberto Porzio, Marco Comaschi
    92-101
    DOI: https://doi.org/10.33393/grhta.2016.414

  • Costs of Tiotropium Bromide Delivered via the Respimat® Inhaler in COPD Patients in Italy

    Sergio Iannazzo, Chiara Distante, Angelo Guido Corsico
    102-109
    DOI: https://doi.org/10.33393/grhta.2016.415

  • Economic Evaluation of Nevirapine plus Raltegravir as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1 Infected Patients

    Roberto Ravasio, Fabio Rigo, Emanuela Lattuada, Ercole Concia, Massimiliano Lanzafame
    110-114
    DOI: https://doi.org/10.33393/grhta.2016.416